New or Novel Oral Anti Coagulants Test


New or novel oral anticoagulants (DOACs) include direct inhibitors of thrombin (eg dabigatran) as well as factor Xa (eg rivaroxaban, apixaban and edoxaban). The latter are difficult to quantitate using current clotting methods and chromogenic assays for individual DOACs have been developed. DOAC test reagent is a modified phospholipid-rich dilute Russells viper venom reagent with enhanced sensititivity to the new oral anti-coagulants. The reagent is ready for use and stable for approximately 1 year stored at 4°C.

We are currently offering free samples for trial. Contact us for more details.

X9211 - 6 x 8m vials